Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?

For years, sufficient progress has been made in treating heart failure following myocardial infarction; however, the social and economic burdens and the costs to world health systems remain high. Moreover, treatment advances have not resolved the underlying problem of functional heart tissue loss. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Roura, Santiago, Gálvez-Montón, Carolina, Mirabel, Clémentine, Vives, Joaquim, Bayes-Genis, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658929/
https://www.ncbi.nlm.nih.gov/pubmed/29078809
http://dx.doi.org/10.1186/s13287-017-0695-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658929/
https://www.ncbi.nlm.nih.gov/pubmed/29078809
http://dx.doi.org/10.1186/s13287-017-0695-y

Ejemplares similares